Sort by
Refine Your Search
-
training, and a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new
-
to support in-process and release testing for GMP Manufacturing and gene and cellular immunotherapy products. This fast-paced lab uses cutting-edge technology for clinical immunotherapeutic programs, including
-
regarding clinical research. Responsible for ensuring protocol compliance by staff and providing recommendations for corrective action when necessary. Meet regularly with disease program leaders
-
a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer
-
programs or institutional core laboratories. Individuals appointed as staff scientists will receive a one-year fixed-term contract. Your qualifications should include: The Staff Scientist must possess, at a
-
. Extensive prior experience in immunology or a closely related field. Preferred qualifications: Ph.D. or equivalent degree and 5 or more years of postdoctoral experience. Programming experience (R, Python
-
. · Extensive experience with leading internal and external audit activities. · Quality management certification from an accredited program is preferred · Knowledgeable and experienced with
-
, bioengineering, and data science, Dr. Chen leads an active research program focused on noncoding RNAs and endothelial stress response. Her team integrates innovative high-throughput sequencing technologies
-
a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer
-
a broad philanthropy program that powers its work. City of Hope’s growing national system includes its Los Angeles campus, a network of clinical care locations across Southern California, a new cancer